Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
96.05
-2.70 (-2.73%)
Jul 10, 2026, 9:36 AM EDT - Market open
Spyre Therapeutics Employees
Spyre Therapeutics had 112 employees as of March 31, 2026. The number of employees increased by 39 or 53.42% compared to the same quarter last year.
Employees
112
Change
39
Growth
53.42%
Revenue / Employee
n/a
Profits / Employee
-$1,327,705
Market Cap
8.34B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| ImmunityBio | 691 |
| Crinetics Pharmaceuticals | 594 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
SYRE News
- 7 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire
- 13 days ago - Spyre Therapeutics files automatic mixed securities shelf - TheFly
- 14 days ago - Biotech ETF Index Surges 10% After Rebalance - ETF Trends
- 16 days ago - Spyre Therapeutics price target raised to $135 from $115 at Deutsche Bank - TheFly
- 24 days ago - Spyre Therapeutics price target raised to $100 from $80 at Wedbush - TheFly
- 24 days ago - Spyre Therapeutics price target raised to $112 from $98 at BTIG - TheFly
- 25 days ago - Spyre says bowel disease drug cuts inflammation in mid-stage trial - Reuters
- 25 days ago - Spyre Therapeutics announces SKYLINE trial achieves primary endpoint - TheFly